Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Strongyloidiasis-related lung involvement: too much of a bad thing49
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era47
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel46
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV42
Editorial introductions42
Complexities of cardiomyopathy in septic shock41
La Crosse virus encephalitis in children40
Skin and soft tissue infections in the elderly33
Corticosteroids for viral central nervous system infections33
From diagnosis to management: current perspectives on congenital cytomegalovirus infection31
Surgical management of cystic echinococcosis of the liver29
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside29
Typhoid fever control in the 21st century: where are we now?28
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians28
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?28
New therapies for nontuberculous mycobacterial lung infection27
Fusarium species central nervous system infection25
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response25
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management25
Progress and challenges in human papillomavirus and cervical cancer in southern Africa25
Mycobacterial skin infection25
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients24
Viral meningitis and encephalitis: an update23
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention22
Mpox in people living with HIV22
Tuberculosis molecular bacterial load assay in the management of tuberculosis22
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?21
Malaria in pregnancy: baby steps20
Tick-borne encephalitis20
Resistant herpes simplex virus infections – who, when, and what's new?20
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies19
Does climate change threaten delivery of HIV care in resource-limited settings?19
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach18
Diagnostic stewardship: what impacts antibiotics use?18
Editorial introductions18
Diagnostic approach and update on encephalitis17
Appropriate surgical management in skin and soft tissue infections17
Interventions for polyoma virus-associated hemorrhagic cystitis16
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease16
CMV antiviral stewardship in transplantation – the next frontier16
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis16
Using antibiotics wisely16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV15
Gut microbiome and its clinical implications: exploring the key players in human health15
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections14
Immunotherapeutic approaches to HIV cure and remission14
Update on the treatment of chronic pulmonary aspergillosis14
The microbiota in respiratory tract infections: from association to intervention14
The plumbing problem: rising antimicrobial resistance in building water systems14
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1914
Risk stratification for selecting empiric antibiotherapy during and after COVID-1914
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change13
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?13
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities13
Editorial: Pathogenesis and immune response – editorial13
Editorial introductions13
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives12
Childhood tuberculosis12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
Short treatment duration for community-acquired pneumonia12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Travellers’ diarrhoea – solidifying our knowledgebase11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
The disease burden of respiratory syncytial virus in Infants11
An overview of risk factors, management and prevention of cochlear implant infections11
Update on drug treatments for multidrug resistant tuberculosis11
The microbiome as a biomarker of anal precancerous lesions in people with HIV11
Respiratory metagenomics: route to routine service11
Data science for pediatric infectious disease: utilizing COVID-19 as a model11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
Short-course antibiotic strategies for ventilator-associated pneumonia10
Skin and soft tissue infections in solid organ transplants10
Identifying patients with difficult-to-treat acute bacterial skin infections10
Urinary tract infections in immunocompromised patients10
Novel techniques in the treatment of skin and soft tissue infection10
Burden of influenza in the elderly: a narrative review10
Immune responses and severe dengue: what have we learned?9
Neurobrucellosis9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
The evolution of knowledge for treating Gram-negative bacterial infections9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
A new era of HIV care for age-associated multimorbidity9
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Therapeutic agents for the treatment of human mpox9
Chagas disease in the immunocompromised host9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Updates on the neurological manifestations of SARS-CoV-2 infection9
Antibiotic treatment of acute bacterial skin and skin structure infections9
0.10425090789795